Rechallenge with Anti-PD-1 Inhibitors in Patients with Recurrent Gynecologic Malignancies

PURPOSE: We investigated the treatment outcomes of immune checkpoint inhibitor (ICI) rechallenge in patients with recurrent gynecologic cancers. MATERIALS AND METHODS: We retrospectively reviewed the medical records of 20 patients who underwent rechallenge with PD-1 inhibitors for recurrent gynecolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Migang, Chang, Chi-Son, Choi, Min Chul, Lee, Jeong-Won, Park, Hyun, Joo, Won Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522879/
https://www.ncbi.nlm.nih.gov/pubmed/37727917
http://dx.doi.org/10.3349/ymj.2023.0063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522879/
https://www.ncbi.nlm.nih.gov/pubmed/37727917
http://dx.doi.org/10.3349/ymj.2023.0063

Ejemplares similares